Ethics of randomized clinical trials and the 'ALARA' approach

Acta Oncologica

Volumn 38, Issue 1, 1999, Pages 99-105

  Zwitter, Matjaz ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; GOOD CLINICAL PRACTICE; MEDICAL ETHICS; METHODOLOGY; PATIENT RIGHT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

ETHICS, MEDICAL; HUMANS; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS;

EID: 0033018194     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699431870     Document Type: Article

References (46)

1. Fibiger J. Om serumbehandling af difteri. Hospitalstidende 1898; 6: 309-25.
2. Fibiger J. Om serumbehandling af difteri. II. Kruppatienter. Hospitalstidende 1898; 6: 337-50.
3. Lewis S. Arrowsmith. New York: Harcourt, 1925.
4. Segelov E, Tattersall MHN, Coates AS. Redressing the balance - the ethics of not entering an eligible patient on a randomised clinical trial. Ann Oncol 1992; 3: 103-5.
5. Passamani E. Clinical trials - are they ethical? New Engl J Med 1991, 324: 1589-92.
6. Kopelman L. Consent in randomized clinical trials: are there moral or design problems? J Med Philos 1986; 11: 317-45.
7. Gifford F. Community-equipoise and the ethics of randomised clinical trials. Bioethics 1995; 9: 127-48.
8. Royall RM. Ignorance and altruism. J Clin Ethics 1992; 3: 229-30.
9. Dudley HAF. Informed consent in surgical trials. Br Med J 1984; 289: 937-8.
10. Taylor KM, Margolese RG, Soskolne CL. Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. New Engl J Med 1984; 310: 1363-7.
11. Cocking D, Oakley J. Medical experimentation, informed consent and using people. Bioethics 1994; 8: 293-311.
12. Hellman S, Hellman DS. Of mice but not men. Problems of the randomized clinical trial. New Engl J Med 1991; 324: 1585-9.
13. Zwitter M, Golouh R. Introduction to ethical analysis. Radiol Oncol 1996, 30: 305-9.
14. Beauchamp TL, Childress JF. Principles of biomedical ethics. 4th ed. New York: Oxford University Press, 1994.
15. Gillon R. Medical ethics: four principles plus attention to scope. Br Med J 1994; 309: 184-8.
16. Thornton HM. Breast cancer trials: a patient's viewpoint. Lancet 1992; 339: 44-5.
17. Altman DG. Better reporting of randomised controlled trials: The CONSORT statement. Br Med J 1996; 313: 570-1.
18. Williams CJ, Zwitter M. Informed consent in European multicentre randomised clinical trials - are patients really informed? Eur J Cancer 1994; 30: 907-10.
19. Zwitter M, Tobias JS. A survey of the ethical considerations in randomised trials for lung cancer. Lung Cancer 1998; 19: 197-200.
20. Minogue BP, Palmer-Fernandez G, Udell L, Waller BN. Individual autonomy and the double-blind controlled experiment: the case of desperate volunteers. J Med Philosophy 1995; 20: 43-55.
21. Baum M. Do we need informed consent? Lancet 1986; 2: 911-2.
22. Stiller CA. Centralised treatment, entry to trials and survival. Br J Cancer 1994; 70: 352-62.
23. Machin D. Interim analysis and ethical issues in the conduct of trials. In: Williams CJ, ed. Introducing new treatments for cancer: practical, ethical and legal problems. Chichester: Wiley, 1992: 203-15.
24. Gifford F. The conflict between randomized clinical trials and the therapeutic obligation. J Med Philos 1986; 11: 347-66.
25. Byar DP. Design considerations for AIDS trials. New Engl J Med 1990; 323: 1343-8.
26. Tobias JS, Souhami RL. Fully informed consent can be needlessly cruel. Br Med J 1993; 307: 1199-201.
27. Moore MJ, O'Sullivan B, Tannock IF. How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 1988; 6: 1736-45.
28. Mackillop WJ, Ward GK, O'Sullivan B. The use of expert surrogates to evaluate clinical trials in non-small cell lung cancer. Br J Cancer 1986; 54: 661-7.
29. Nilstun T. Paternalism and health behavior. In: Gochman DS, ed. Handbook of health behavior research IV: relevance for professionals and issues for the future. New York: Plenum, 1996: 203-13.
30. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991; 337: 867-72.
31. Begg CB, Berlin JA. Publication bias and dissemination of clinical research. J Natl Cancer Inst 1989; 81: 107-15.
32. Dickersin K, Min Y-I, Meinert CL. Factors influencing publication of research results. JAMA 1992; 267: 374-8.
33. De Bellefeuille C, Morrison CA, Tannock IF. The fate of abstracts submitted to a cancer meeting: factors which influence presentation and subsequent publication. Ann Oncol 1992; 3: 187-91.
34. Scherer RW, Dickersin K, Langenberg P. Full publication of results initially presented in abstracts. JAMA 1994; 272: 158-62.
35. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997; 315: 629-34.
36. Thornton H. Clinical trials - a brave new partnership? J Med Ethics 1994; 20: 19-22.
37. Baum M. Clinical trials - a brave new partnership: a response to Mrs. Thornton. J Med Ethics 1994; 20: 23-5.
38. Baum M. New approach for recruitment into randomised clinical trials. Lancet 1993; 341: 812-3.
39. Brahams D. Randomised trials and informed consent. Lancet 1988; 2: 1033-4.
40. Brewin CR, Bradley C. Patient preferences and randomised clinical trials. Br Med J 1989; 299: 313-5.
41. Jack WJL, Chetty U, Rodger A. Recruitment to a prospective breast conservation trial: why are so few patients randomised? Br Med J 1990; 301: 83-5.
42. Hancock BW, Aitken M, Radstone C, Vaughan Hudson G. Why don't cancer patients get entered into clinical trials? Experience of the Sheffield lymphoma group's collaboration in British national lymphoma iInvestigation studies. Br Med J 1997; 314: 36-7.
43. Zwitter M. Communication with the patient in clinical research. Ann NY Acad Sci 1997; 809: 83-96.
44. Halsey NA, Sommer A, Henderson DA, Black RE. Ethics and international research. Research standards are the same throughout the world; medical care is not. Br Med J 1997; 315: 965-6.
45. Wilmshurst P. Scientific imperialism. If they won't benefit from the findings, poor people in the developing world shouldn't be used in research. Br Med J 1997; 314: 840-1.
46. Cleaton-Jones PE. Availability of antiretroviral therapy after clinical trials with HIV infected patients are ended. Br Med J 1997; 314: 887-91.